Kappa Free Light Chains Reflect Treatment Response and Progression Independent of Focal Inflammation in Multiple Sclerosis

Documenti analoghi

• Brain‐Derived Tau as an Outcome Marker in Guillain‐Barré Syndrome: A Retrospective Cohort Study
  di: Brynhildur Hafsteinsdóttir, et al.
  Pubblicazione: (2025)
• The Effect of Gadolinium on Synthetic Magnetic Resonance Quantitative Imaging
  di: Lenka Novakova, et al.
  Pubblicazione: (2025)
• Serum sTREM2 Levels and Disability Progression in Patients With Primary Progressive Multiple Sclerosis
  di: Nicolás Fissolo, et al.
  Pubblicazione: (2026)
• Determinants and Biomarkers of Progression Independent of Relapses in Multiple Sclerosis
  di: Massimiliano Calabrese, et al.
  Pubblicazione: (2024)
• Contribution of Polygenic Scores to Progression Independent of Relapse Activity in Multiple Sclerosis
  di: Ferdinando Clarelli, et al.
  Pubblicazione: (2025)